Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Quentis Therapeutics
430 E 29th St., Suite 1005
New York, NY 10016
Phone: 646-440-9249

Quentis Therapeutics is a preclinical stage biotechnology company that is translating novel biology into new therapeutic approaches to help more cancer patients benefit from immunotherapy. Based on our deep expertise in endoplasmic reticulum (ER) stress biology and the tumor microenvironment, we are pioneering first-in-class ER stress response modulators to boost the immune system's ability to fight cancer. Our lead program is a first-in-class IRE1a inhibitor. We are pursuing multiple additional ER stress pathway targets in the tumor micro-environment, as well as in other diseases where ER stress plays an important role.

Key Contact
Michael Aberman
Funding Events

02/28/18 $48,000,000 Series A AbbVie Biotech Ventures
Alexandria Real Estate Equities
New York Ventures
Polaris Partners
Taiho Ventures
Versant Ventures
Yonghua Capital